Hepatitis C Drug Shows Promise Against Deadly Hepatitis E Virus
Bemnifosbuvir blocks hepatitis E replication in lab tests, offering hope for treating a virus that kills 70,000 people annually.
516 articles in this topic
Bemnifosbuvir blocks hepatitis E replication in lab tests, offering hope for treating a virus that kills 70,000 people annually.
New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.
Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.
Researchers develop CAR-T cell therapy specifically targeting KRAS mutations, offering new hope for treating previously difficult cancers.
Harvard researcher calls for urgent action linking cancer, climate change, and fossil fuel pollution in groundbreaking analysis.
Leading oncologists address current controversies in breast cancer screening guidelines and practices.
New review reveals how senescent cells both prevent and promote cancer, opening therapeutic opportunities.
New study shows PCSK9 inhibitor prevents cardiovascular events in high-risk diabetes patients without existing heart disease.
New study finds 27% of patients with treatment-resistant hypertension have elevated cortisol levels that could explain medication failures.
New research reveals colorectal cancer has distinct microbial communities that could improve diagnosis and personalized treatment approaches.
New review reveals key diagnostic features of superficial angiomyxoma, a rare benign tumor affecting middle-aged adults.
New research reveals how a specific protein causes anemia in myelodysplastic syndromes and predicts treatment response.